Clinical trials
Anus Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Charite University, Berlin, Germany | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Goethe University | 1 |
| Incyte Corporation | 1 |
| Juergen Debus | 1 |
| Ludwig-Maximilians - University of Munich | 1 |
| Novartis Pharmaceuticals | 1 |
| Oryx GmbH & Co. KG | 1 |
| University Hospital, Essen | 1 |
| University of Erlangen-Nürnberg Medical School | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anus Neoplasms | 10 |
| Carcinoma, Squamous Cell | 2 |
| Esophageal Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Hyperthermia | 2 |
| Rectal Neoplasms | 2 |
| Uterine Cervical Neoplasms | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Adenocarcinoma, Clear Cell | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.